CD Bioparticles Introduces Innovative Agonist-Based Adjuvants for Enhanced Vaccine Efficacy
CD Bioparticles launches new line of Agonist-Based Adjuvants to support researchers.
CD Bioparticles, a leading manufacturer and supplier of numerous drug delivery products and services, is excited to announce the launch of its new line of Agonist-Based Adjuvants to support researchers in various fields, including vaccines and immunotherapeutics. These new adjuvants are designed to...
0 Comments
0 Shares